Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SLC39A14: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
SLC39A14 encodes a zinc and manganese transporter with critical roles in metal homeostasis. Mutations cause manganese metabolism disorders with parkinsonian features, and dysregulation contributes to metal-induced neurotoxicity in Parkinson's disease and other neurodegenerative conditions.
No AI portrait yet
| Gene Symbol | SLC39A14 |
| Full Name | Solute Carrier Family 39 Member 14 (Zip14) |
| Chromosome | 8p22 |
| Protein Type | Transporter |
| Function | is a membrane transporter that facilitates the uptake of zinc and manganese into cells. |
| Amino Acids | 648 aa |
| UniProt ID | [Q5HYNY4](https://www.uniprot.org/uniprot/Q5HYNY4) |
| Ensembl ID | ENSG00000146373 |
| GeneCards | SLC39A14 |
| Human Protein Atlas | SLC39A14 |
| Length | 648 amino acids |
| Topology | 8 transmembrane domains |
| N-terminus | Extracellular with potential metal-binding sites |
| C-terminus | Intracellular with regulatory motifs |
| Conserved motifs | H-XHXH and H-X4-H in transmembrane domains for metal binding |
| Associated Diseases | neurodegeneration |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
SLC39A14["SLC39A14"]
neurodegeneration["neurodegeneration"]
SLC39A14 -->|"implicated in"| neurodegeneration
Neurodegenerative_Conditions{"Neurodegenerative Conditions"}
SLC39A14 -->|"implicated in"| Neurodegenerative_Conditions
Parkinson{"Parkinson"}
SLC39A14 -->|"implicated in"| Parkinson
Parkinson_S_Disease{"Parkinson'S Disease"}
SLC39A14 -->|"implicated in"| Parkinson_S_Disease
style SLC39A14 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#fff
style Parkinson fill:#4a1a1a,stroke:#ef5350,stroke-width:1px,color:#ef5350
style Parkinson_S_Disease fill:#4a1a1a,stroke:#ef5350,stroke-width:1px,color:#ef5350
style Neurodegenerative_Conditions fill:#4a1a1a,stroke:#ef5350,stroke-width:1px,color:#ef5350| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning SLC39A14 in their description or question text
No additional research found